WI
Windlas Biotech Limited
WINDLAS.NS · NSE
₹1,100.00 -2.59% (-₹29.25)
1M +20.98%
Market Cap ₹23.9B
P/E Ratio 35.98x
Div. Yield 0.56%
ROE 12.33%
Bulios Fair Price
₹820.96
25.4% downside
Trenutna cena
₹1,100
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica WINDLAS.NS trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
5/9Valuation
22 /100
Expensive P/FCF 90.10x
P/S 2.54x
P/B 4.12x
Growth
93 /100
Growing Rev. growth 20.98%
Book val. growth 13.03%
EPS growth 16.50%
Profitability
34 /100
Moderate Net margin 7.05%
Op. margin 7.90%
FCF margin 2.82%
Quality
61 /100
Average ROE 12.33%
ROA 7.32%
Asset turnover 1.04x
Debt
100 /100
Low Current ratio 1.95x
Int. coverage 16.05x
Net debt/EBITDA 0.28x
Stability
77 /100
Stable Rev. volatility 2.10%
EPS volatility 20.77%
Profitable years 6
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o WINDLAS.NS
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Komal Gupta
Employees
1,385
Headquarters
Dehradun